Exploratory Lapatinib (Positron Emission Tomography) PET Study in Subjects With Breast Cancer
Status: COMPLETED
Study type: INTERVENTIONAL
Conditions: Cancer
Interventions: DRUG: Lapatinib|DRUG: [11C] lapatinib
Sponsor: GlaxoSmithKline